Ambu A/S

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

16.11.2026 11:59:02 CET | Ambu A/S | Changes in company's own shares

On 5 November 2026, Ambu announced a share buyback program (company announcement no. 3 2026/27). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                             

During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027. The repurchased shares are bought with the purpose of reducing the share capital in accordance with Article 5(2)(a) in MAR.

The following transactions have been made under the program from 9 November 2026 to 13 November 2026:  

  

Number of shares 

Average purchase price, DKK 

Transaction value, DKK 

Accumulated under the program since last announcement 

0 

0 

0 

2026.11.09 

45,000 

88.2600 

3,971,700 

2026.11.10 

45,000 

86.8600 

3,908,700 

2026.11.11 

45,000 

86.8500 

3,908,250 

2026.11.12 

43,000 

87.5000 

3,762,500 

2026.11.13 

38,000 

90.1100 

3,424,180 

Accumulated under the program 

216,000 

87.8488 

18,975,330 

Following the transactions disclosed above, the remaining amount available under the program is DKK 381,024,670. Ambu now owns 8,857,687 treasury shares, corresponding to 3.3% of the share capital. 

Contacts

Tine Bjørn Schmidt

Director of Global Brand & Communications

tisc@ambu.com

Lisa Bedell Clive

Head of Investor Relations

licl@ambu.com

About Ambu A/S

Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

Attachments

Subscribe to our company announcements

Keep up to date with our company announcements by subscribing.

Visit our pressroom and see more company announcements from us.

Our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye